MAIDEN Trademark

Trademark Overview

On Tuesday, November 10, 2020, a trademark application was filed for MAIDEN with the United States Patent and Trademark Office. The USPTO has given the MAIDEN trademark a serial number of 90308528. The federal status of this trademark filing is REGISTERED as of Tuesday, December 13, 2022. This trademark is owned by Enveda Therapeutics, Inc.. The MAIDEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development services for the discovery of novel patentable chemical molecules; platform as a service (PAAS) featuring computer software technology platform for the discovery of novel patentable chemical molecules
maiden

General Information

Serial Number90308528
Word MarkMAIDEN
Filing DateTuesday, November 10, 2020
Status700 - REGISTERED
Status DateTuesday, December 13, 2022
Registration Number6925624
Registration DateTuesday, December 13, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 24, 2021

Trademark Statements

Goods and ServicesPharmaceutical research and development services for the discovery of novel patentable chemical molecules; platform as a service (PAAS) featuring computer software technology platform for the discovery of novel patentable chemical molecules

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 8, 2021
Primary Code042
First Use Anywhere DateThursday, October 1, 2020
First Use In Commerce DateThursday, October 1, 2020

Trademark Owner History

Party NameEnveda Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301
Party NameEnveda Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301
Party NameEnveda Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Trademark Events

Event DateEvent Description
Monday, December 18, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, December 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 13, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 13, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, November 10, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 9, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 2, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 19, 2022USE AMENDMENT FILED
Wednesday, November 2, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 19, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, April 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 19, 2022SOU EXTENSION 1 GRANTED
Tuesday, April 19, 2022SOU EXTENSION 1 FILED
Tuesday, April 19, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 19, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 24, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 24, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 4, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 24, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 24, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 24, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 5, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 5, 2021NON-FINAL ACTION E-MAILED
Wednesday, May 5, 2021NON-FINAL ACTION WRITTEN
Monday, April 19, 2021ASSIGNED TO EXAMINER
Friday, January 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

maiden patentable molecules platform novel chemical discovery featuring computer software technology